LSBPW
Income statement / Annual
Last year (2024), LakeShore Biopharma Co., Ltd.'s total revenue was $573.42 M,
a decrease of 16.56% from the previous year.
In 2024, LakeShore Biopharma Co., Ltd.'s net income was -$433.46 M.
See LakeShore Biopharma Co., Ltd.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
Operating Revenue |
$573.42 M |
$687.20 M |
$502.95 M |
$257.02 M |
Cost of Revenue |
$117.69 M
|
$153.36 M
|
$117.07 M
|
$59.66 M
|
Gross Profit |
$455.73 M
|
$533.84 M
|
$385.88 M
|
$197.36 M
|
Gross Profit Ratio |
0.79
|
0.78
|
0.77
|
0.77
|
Research and Development Expenses |
$302.80 M
|
$318.70 M
|
$211.22 M
|
$94.39 M
|
General & Administrative Expenses |
$147.65 M
|
$81.76 M
|
$107.05 M
|
$138.89 M
|
Selling & Marketing Expenses |
$280.45 M
|
$251.56 M
|
$165.72 M
|
$69.44 M
|
Selling, General & Administrative Expenses |
$428.09 M
|
$333.32 M
|
$549,179.00
|
$208.33 M
|
Other Expenses |
$170.67 M
|
-$199,452.00
|
-$2.41 M
|
-$22.36 M
|
Operating Expenses |
$901.56 M
|
$647.15 M
|
$549,179.00
|
$319.68 M
|
Cost And Expenses |
$1.02 B
|
$800.51 M
|
$549,179.00
|
$379.33 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$44.34 M
|
$30.86 M
|
$2.72 M
|
$29.69 M
|
Depreciation & Amortization |
$42.19 M
|
$36.69 M
|
$31.15 M
|
$27.91 M
|
EBITDA |
-$368.66 M |
-$76.80 M |
-$67.20 M |
-$116.78 M |
EBITDA Ratio |
-0.64
|
-0.11
|
-0
|
-0.45
|
Operating Income Ratio |
-0.78
|
-0.2
|
-0
|
-0.49
|
Total Other Income/Expenses Net |
-$9.36 M
|
-$4.96 M
|
$17.89 M
|
-$48.52 M
|
Income Before Tax |
-$455.19 M
|
-$144.35 M
|
-$545,727.00
|
-$174.37 M
|
Income Before Tax Ratio |
-0.79
|
-0.21
|
-0
|
-0.68
|
Income Tax Expense |
-$21.73 M
|
$1.13 M
|
$4.94 M
|
$17.45 M
|
Net Income |
-$433.46 M
|
-$145.48 M
|
-$545,727.00
|
-$191.83 M
|
Net Income Ratio |
-0.76
|
-0.21
|
-0
|
-0.75
|
EPS |
-4.05 |
-1.88 |
-0.0185 |
-6.67 |
EPS Diluted |
-4.05 |
-1.88 |
-0.0185 |
-6.67 |
Weighted Average Shares Out |
$106.92 M
|
$77.42 M
|
$29.50 M
|
$28.75 M
|
Weighted Average Shares Out Diluted |
$106.92 M
|
$77.42 M
|
$29.50 M
|
$28.75 M
|
Link |
|
|
|
|